ELTX
Elicio TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ELTX Profile
Elicio Therapeutics Inc
A biopharmaceutical company focused on novel small molecule therapeutics to address fibrotic diseases
451 D Street, 5th Floor, Boston, Massachusetts 02210
--
Elicio Therapeutics Inc was incorporated in Delaware on April 6, 1998. The company is a clinical-stage biotechnology company developing a novel immunotherapy pipeline for the treatment of cancer and disease. By combining expertise in immunology and immunotherapy, Elicio is designing investigational amphiphilic (AMP) immunotherapies designed to precisely target and fully engage lymph nodes. Elicio is designing node-targeting amplifiers, immunomodulators, adjuvants and vaccines for a range of aggressive cancers and infectious diseases.
